NCT07013344 Association of Plasma N-terminal Pro-Brain Natriuretic Peptide Levels With the Burden of Coronary Artery Disease
| NCT ID | NCT07013344 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Ospedale San Raffaele |
| Condition | Chronic Coronary Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 800 participants |
| Start Date | 2021-09-01 |
| Primary Completion | 2025-06-29 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 800 participants in total. It began in 2021-09-01 with a primary completion date of 2025-06-29.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aim to investigate the association between plasma NT-proBNP levels and the presence, extent and severity of stenosis in patients with suspected coronary artery disease.
Eligibility Criteria
Inclusion Criteria: * patient referred for elective coronary angiography due to suspected CAD. * NT-proBNP measurement during hospitalization Exclusion Criteria: * heart failure * severe valvular disease * atrial fibrillation * severe chronic kidney disease (eGFR \< 30 mL/min) * prior coronary artery bypass grafting * age over 80 years
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07013344 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Coronary Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07013344 currently recruiting?
Yes, NCT07013344 is actively recruiting participants. Contact the research team at gaspardone.carlo@hsr.it for enrollment information.
Where is the NCT07013344 trial being conducted?
This trial is being conducted at Milan, Italy, Milan, Italy.
Who is sponsoring the NCT07013344 clinical trial?
NCT07013344 is sponsored by IRCCS Ospedale San Raffaele. The trial plans to enroll 800 participants.